GLP Watchdog

Brello Health vs Fridays

Neither Brello Health nor Fridays has an FDA warning letter on record. No price lines up like for like. They share compounded semaglutide injection, but Brello Health's $157.72 is a 3-month prepaid rate.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Brello Health / Fridays

Brello Health logo

Brello Health

8.1/10

Fridays logo

Fridays

5.8/10

FDA warning letters
None on record
None on record
Pharmacy
Lowest standing price
$157.72/moCompounded semaglutide injection, 3-month prepaid plan
$249/moCompounded semaglutide injection
States
40 states and DC
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Brello Health
Visit Fridays

Neither Brello Health nor Fridays pays us. Links to them earn nothing. Scores: Brello Health 8.1, Fridays 5.8. How we are paid

What the record shows

  1. 01

    Neither Brello Health nor Fridays has an FDA warning letter on record.

  2. 02

    Brello Health names SouthEnd Pharmacy, a 503A pharmacy. Fridays names four pharmacies.

  3. 03

    No price lines up like for like. They share compounded semaglutide injection, but Brello Health's $157.72 is a 3-month prepaid rate.

  4. 04

    Only Fridays lists a price for brand-name semaglutide pen and brand-name tirzepatide pen.

  5. 05

    Brello Health lists 40 states and DC. Fridays publishes no state list.

  6. 06

    Brello Health holds you to a 3-month prepay (6-month plan optional); Fridays states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Brello Health

Fridays

Compounded semaglutide injection

$157.72/mo

3-month prepaid plan; not compared

$249/mo

$2,988 a year

Compounded tirzepatide injection

$176.69/mo

6-month prepaid plan; not compared

$359/mo

$4,308 a year

Brand-name semaglutide pen
Not sold or not priced

$1,498/mo

$17,976 a year

Brand-name tirzepatide pen
Not sold or not priced

$1,828/mo

$21,936 a year

Price includes
Medication, clinician visits
Medication, clinician visits, coaching
Cancel any time
No
Yes, stated
Minimum term
3-month prepay (6-month plan optional)
None on the monthly plan; 3, 6 and 12-month plans are prepaid
Refunds
Full refund before a prescription; $50 fee within 24 hours after; none once dispensed
Fees are non-refundable except for medical disqualification, billing errors or where the law requires

Read off each seller’s own pages. Brello Health: October 25, 2026. Fridays: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Brello Health

8.1/10

The record gives Brello Health no edge on this pair.

  • Minimum commitment before you can cancel
  • Lowest price is a 3-month prepaid rate
Visit Brello Health

The case for Fridays

5.8/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Brello Health does not price
  • States you can cancel at any time
  • Publishes no state list
Visit Fridays

Scores

Brello Health 8.1 · Fridays 5.8 out of 10. Six weighted parts.

Value25%

6.0A
vs
B
3.4

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

10.0A
vs
B
5.5

Accessibility10%

8.4A
vs
B
5.0

Support10%

5.5A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Brello Health vs Fridays: questions

Neither Brello Health nor Fridays has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Brello Health names SouthEnd Pharmacy, a 503A pharmacy. Fridays names four pharmacies. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like. They share compounded semaglutide injection, but Brello Health's $157.72 is a 3-month prepaid rate. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Brello Health has a minimum term (3-month prepay (6-month plan optional)). Fridays states you can cancel at any time; refunds: fees are non-refundable except for medical disqualification, billing errors or where the law requires.
Neither Brello Health nor Fridays pays us. Links to them earn nothing. Scores: Brello Health 8.1, Fridays 5.8.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks